Cover Image
市場調查報告書

全球體外診斷(IVD)市場報告

Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition

出版商 Koncept Analytics 商品編碼 223486
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
全球體外診斷(IVD)市場報告 Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition
出版日期: 2015年12月11日 內容資訊: 英文 66 Pages
簡介

全球體外診斷市場中,血糖監測系統及臨床化學部門相對日趨成熟、穩定化。今後隨著個體化醫療的增加趨勢,分子診斷學部門將在嚴格的法令規制下仍大幅成長。市場整體促進成長要素有別於學名藥的宏觀經濟要素,有糖尿病患者的劇增,醫療相關的高科技設備銷售額增加,疾病的複雜性,心肌肌鈣蛋白檢測的增加等。現在產業值得一提的趨勢有維他命D檢測市場的新成長、基因譯解市場,腫瘤學上搭配診斷的活用,再加上診斷的重要性提升等。然而業界仍然面臨狹隘經濟的瓶頸,臨床檢查服務上醫療費給付問題、IVD造成降低研究所開發檢查的利益、政府IVD檢查的法規及基因檢查的嚴格法規等課題。

本報告提供體外診斷用醫藥品(IVD)的全球市場相關分析,提供您整體市場結構和成長推動因素,法律規範,競爭環境,主要市場趨勢,主要企業簡介與策略等資訊,同時也推算今後的市場趨勢,提供您結果。

第1章 體外診斷(IDV):概要

  • IVD產品的種類
  • IVD試驗的種類
  • 市場分類
    • 各技術
    • 各終端用戶
  • IVD的利用法
  • IVD的價值鏈

第2章 IVD市場分析

  • 全球市場
    • 市場價值
    • 各地區明細
    • 技術類別市場
    • 各產品種類市場
    • 各檢驗部位市場
  • 分子診斷
    • 檢驗各區域
  • 免疫學的檢測
  • 地區市場
    • 歐洲
      • 市場價格
      • 各國明細
    • 中國

第3章 市場動態

  • 成長推動因素
    • 全球性醫療費的增加
    • 全球性老年人口的增加
    • 糖尿病患者數的急劇增加
    • 全球性國民所得毛額的增加
    • 醫療用高科技設備的銷售額增加
    • 疾病的複雜性的增加
    • 心肌肌鈣蛋白檢測的增加
  • 主要趨勢
    • 維他命D檢測市場-新的成長部門
    • 支配Illumina-基因譯解市場
    • 診斷的重要性高漲
    • 腫瘤學的搭配診斷的活用
  • 課題
    • 以市場內為中心的狹隘經濟瓶頸
    • 遺傳基因檢驗更加嚴格的法規
    • 由於IVD的減少利益的研究所開發檢驗
    • 政府對IVD檢驗的法規
    • 臨床檢驗服務的範圍與醫療費給付問題

第4章 競爭環境

  • 全球市場
  • 各部門的競爭情形
    • 臨床化學
    • 血糖檢驗
    • 微生物學
    • 血液學及流式細胞技術
    • 分子生物學診斷
    • 免疫學的檢測
    • 細胞診斷
  • 中國

第5章 企業簡介

  • Abbott Laboratories
    • 營業內容
    • 財務指標
    • 產業策略
  • Siemens AG
    • 營業內容
    • 財務指標
    • 產業策略
  • Roche Holdings AG
    • 營業內容
    • 財務指標
    • 產業策略
  • Johnson & Johnson
    • 營業內容
    • 財務指標
    • 產業策略

第6章 市場展望

  • 市場預測
  • 預測手法
    • 獨立·因變數
    • 相關分析
    • 迴歸分析

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The diagnostic industry is widely classified into two types: In-vitro diagnostics and In-vivo diagnostics. In-vitro tests are executed in glass test tubes, while In-vivo diagnostics tests are executed inside a patient's body. IVD products are indeed designed and produced for collecting samples derived from the patient's body and scrutinizing them outside, which are commonly conducted in hospitals, clinics and labs and in personal settings. Apart from the application of IVDs in medical diagnosis and health screening such as checking blood of signs for infections, or urine for the presence of glucose, they are also used in genetic testing, genomics, veterinary diagnostics, food testing, environmental testing, and research.

As per the "Global IVD market report", market segments such as blood glucose monitoring and clinical chemistry are relatively mature and stable. However, with growing personalized medical treatment trend, molecular diagnostics market is expected to grow significantly with strict regulatory measures.

The key factors driving the market growth apart from generic macro-economic factors include accelerating diabetic population, increasing sales of medical technological devices, increasing complexity of diseases, and development of cardiac troponin assays. Some of the noteworthy trends observed in the industry are newly growing vitamin D testing market, genome sequencing market, usage of companion diagnostics in oncology, and increased importance of diagnostics. However, the industry remains exposed to certain challenges such as narrow economic moats in diagnostic market, reimbursement issues in clinical laboratory services, laboratory-developed tests waning IVD profits, and government regulation for IVD tests and stringent in genetic based tests.

The report provides a comprehensive study of global in-vitro diagnostic market covering regional markets and major segments. The competition in the global in-vitro diagnostic market is highly amalgamated with large players like Abbott, Siemens, Roche and Johnson and Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for their long term growth.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table of Contents

1. Overview

  • 1.1 Types of IVD Products
  • 1.2 Types of IVD Tests
  • 1.3 Market Segments
    • 1.3.1 Technology Type
    • 1.3.2 End-User Segmentation
  • 1.4 Uses of IVDs
  • 1.5 IVD Value Chain

2. IVD Market Analysis

  • 2.1 Global Market
    • Market Value
    • Regional Breakdown
    • 2.1.1 IVD Market by Technology Type
    • 2.1.2 IVD Market by Product Type
    • 2.1.3 IVD Market by Test Location
  • 2.2 Molecular Diagnostics
    • 2.2.1 Molecular Diagnostic Market by Test Category
  • 2.3 Immunoassays
  • 2.4 Regional Markets
    • 2.4.1 Europe
      • Market Value
      • Market Share by Countries
    • 2.4.2 China

3. Market Dynamics

  • 3.1 Growth Drivers
    • 3.1.1 Rising Global Healthcare Expense
    • 3.1.2 Increasing Global Ageing Population
    • 3.1.3 Accelerating Global Diabetic Population
    • 3.1.4 Increasing Global Gross National Income
    • 3.1.5 Increasing Sales of Medical Technological Devices
    • 3.1.6 Increasing Complexity of Diseases
    • 3.1.7 Development of Cardiac Troponin Assays
  • 3.2 Key Trends
    • 3.2.1 Vitamin D Testing Market - New Growing Segment
    • 3.2.2 Illumina - Dominating the Genome Sequencing Market
    • 3.2.3 Increased Importance of Diagnostics
    • 3.2.4 Increased Usage of Companion Diagnostic in Oncology
  • 3.3 Challenges
    • 3.3.1 Diagnostic Market Containing Narrow Economic Moats
    • 3.3.2 More Diagnostic Regulation in Genetic Based Tests
    • 3.3.3 Laboratory-Developed Tests Waning IVD Profits
    • 3.3.4 Government Regulation for IVD Tests
    • 3.3.5 Coverage and Reimbursement of Clinical Laboratory Services

4. Competitive Landscape

  • 4.1 Global Market
  • 4.2 Competition by Segments
    • 4.2.1 Clinical Chemistry
    • 4.2.2 Blood Glucose Testing
    • 4.2.3 Microbiology
    • 4.2.4 Hematology and Flow Cytometry
    • 4.2.5 Molecular Diagnostic
    • 4.2.6 Immunoassay
    • 4.2.7 Tissue Diagnostic
  • 4.3 China

5. Company Profiles

  • 5.1 Abbott Laboratories
    • 5.1.1 Business Overview
    • 5.1.2 Financial Overview
    • 5.1.3 Business Strategies
  • 5.2 Siemens AG
    • 5.2.1 Business Overview
    • 5.2.2 Financial Overview
    • 5.2.3 Business Strategies
  • 5.3 Roche Holdings AG
    • 5.3.1 Business Overview
    • 5.3.2 Financial Overview
    • 5.3.3 Business Strategies
  • 5.4 Johnson & Johnson
    • 5.4.1 Business Overview
    • 5.4.2 Financial Overview
    • 5.4.3 Business Strategies

6. Market Outlook

  • 6.1 Market Forecast
  • 6.2 Forecast Methodology
    • 6.2.1 Dependent and Independent Variables
    • 6.2.2 Correlation Analysis
    • 6.2.3 Regression Analysis

List of Charts

  • IVD Market Segments by Technology Type
  • IVD Market by End Users
  • IVD Value Chain Analysis in Medical Application
  • Global IVD Market Value (2009-2014)
  • Global IVD Market by Geography (2014)
  • Global In-Vitro Diagnostic Device Sales (2011-2014)
  • Global IVD Market Share by Technology Type (2014)
  • Global Clinical and Industrial In-Vitro Market Value (2011-2014)
  • Global Clinical IVD Market by Region (2014)
  • Global Clinical IVD Market by Technology Type (2014)
  • Global IVD Market Share by Product Type (2014)
  • Global IVD Instrumentation Market Share by Segment (2009-2015E)
  • Global IVD Market by Test Location (2014)
  • Global Molecular Diagnostic Market Value (2009-2018E)
  • Molecular Diagnostic Market Share by Test Category (2014)
  • Immunoassay Market Share by Clinical Areas (2014)
  • IVD Market Value in EU27+ EFTA (2009-2014)
  • IVD Market in Europe by Region (2013/2014)
  • IVD Market Share in Europe - by Countries (2014)
  • European IVD Market - by Countries (2014)
  • IVD Market Value in China (2009-2018E)
  • Global Healthcare Expenditure Per Capita (2009-2014E)
  • Global Aging Population Over 65 (2009-2014)
  • World Population with Diabetes, Age Group 20-79 years (2007-2014)
  • Global GDP - World & Regions (2009-2014)
  • Global GNI per Capita - World & Regions (2009-2014)
  • Global Medical Technology Sales (2005-2014)
  • Global IVD Market Share Breakdown by Company (2014)
  • Clinical Chemistry Market Share by Company (2014)
  • Blood Glucose Testing Market Share by Company (2014)
  • Microbiology Market Share by Company (2014)
  • Hematology and Flow Cytometry Market Share by Company (2014)
  • Hemostasis Market Share by Company (2014)
  • Molecular Diagnostic Market Share by Company (2014)
  • Immunoassay Market Share by Company (2014)
  • Immunoassay Infectious Disease Market Share by Company (2014)
  • Immunoassay Hepatitis/Retrovirus Market Share by Company (2014)
  • Immunoassay GI Stool Testing Market Share by Company (2014)
  • Immunoassay Onco/Endocrino-logy Market Share by Company (2014)
  • Immunoassay Nucleic Acid Test Market Share by Company (2014)
  • Tissue Diagnostic Market Share by Company (2014)
  • IVD Market Share by Company in China (2014E)
  • Abbott Laboratories Revenue Share by Business Segments (2014)
  • Abbott Laboratories Revenue and Net Income (2009-2014)
  • Siemens Revenue Share by Business Segments (2015)
  • Siemens Revenue and Net Income (2010-2015)
  • Roche's Revenue Share by Business Segments (2014)
  • Roche's Revenue and Net Income (2009-2014)
  • Revenue Share of Johnson & Johnson's by Business Segments (2014)
  • Revenues and Net Income of Johnson & Johnson (2009-2014)
  • Global In Vitro Diagnostics Market Value Forecast (2013-2020F)

List of Tables

  • IVD Market Key Players-by Segments
  • Country-wise Division of European IVD Market (2014)
  • Economic Moat Comparison by Healthcare Product Industry (2014)
  • Competitive Positioning in Molecular Diagnostic Segment (2014)
  • Dependent & Independent Variables (2009-2014)
  • Correlation Matrix
  • Model Summary - Coefficient of Determination
  • Regression Coefficients Output
Back to Top